CROWN is the first large, phase IIIb trial to evaluate the investigational use of LA Cabenuva versus daily oral therapy in ...

A retrospective study reported high recent use of GLP-1 receptor agonists in people living with HIV at a UK centre, with ...

As the population of people with HIV ages, researchers studied cognitive health changes; 46% of study participants were ...

University of British Columbia news release. The HPV vaccine provides strong, long-lasting protection for women living with ...

Women with HIV have almost twice the risk of CVD compared to women without HIV, while men with HIV have a 44% increased risk ...

ECDC released a report assessing the current situation regarding availability and access to prevention, testing, and ...

Mirum Pharmaceuticals press release. Mirum Pharmaceuticals, Inc. announced the primary endpoint was met in the Phase 3 ...

Among women with steatotic liver disease, HIV was associated with 48% greater adjusted odds of clinically significant ...

Study offered a potential explanation for why neurological complications persist despite antiretroviral treatment.

The virus directly killed an estimated 0.9 million people in 2023, ranking 14th, as global life expectancy climbed back to ...

— HIV infections are projected to decrease 32% among US men who have sex with men by 2035. — Researchers developed a model to identify steps to end the HIV epidemic among this population. — With ...

The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) is working with countries, partners and communities to prepare for a significant expansion in access to lenacapavir for HIV ...